Roche Doubles Down On Collaborations In Immuno-Oncology, No Signs Of Stopping
This article was originally published in The Pink Sheet Daily
Executive Summary
In interview at JP Morgan meeting, Roche oncology partnering exec Jason Coloma celebrates new trial collaborations to advance PD-L1 inhibitor atezolizumab and promises more partnerships are to come.